Biblio

Journal Article
Soh K-S, Kang KA, Ryu YHee. 50 years of bong-han theory and 10 years of primo vascular system. Evid Based Complement Alternat Med. 2013;2013:587827.
Lewis CM, Graves SA, Hernandez R, Valdovinos HF, Barnhart TE, Cai W, Meyerand ME, Nickles RJ, Suzuki M. (52)Mn Production for PET/MRI Tracking Of Human Stem Cells Expressing Divalent Metal Transporter 1 (DMT1). Theranostics. 2015;5(3):227-39.
Fukuzaki Y, Shin H, Kawai HD, Yamanoha B, Kogure S. 532 nm Low-Power Laser Irradiation Facilitates the Migration of GABAergic Neural Stem/Progenitor Cells in Mouse Neocortex. PLoS One. 2015;10(4):e0123833.
Zhou D, Ai Q, Lin L, Gong X, Ge P, Che Q, Wan J, Wen A, Zhang L. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-attenuates LPS/D-Gal-induced acute hepatitis in mice. Innate Immun. 2015.
Fukumura M, Nonoguchi N, Kawabata S, Hiramatsu R, Futamura G, Takeuchi K, Kanemitsu T, Takata T, Tanaka H, Suzuki M, et al. 5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy. Sci Rep. 2023;13(1):10173.
Fujishiro T, Nonoguchi N, Pavliukov M, Ohmura N, Park Y, Kajimoto Y, Ishikawa T, Nakano I, Kuroiwa T. 5-aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents. Photodiagnosis Photodyn Ther. 2018.
Ahmadi BMirza, Noori A, Ashtiani MKazemi, Rajabi S, Talkhabi M. 5-Azacytidine incorporated skeletal muscle-derived hydrogel promotes rat skeletal muscle regeneration. Cells Dev. 2023:203826.
Stübig T, Badbaran A, Luetkens T, Hildebrandt Y, Atanackovic D, Binder TMC, Fehse B, Kröger N. 5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity. Mediators Inflamm. 2014;2014:418292.
Kaur K, Yang J, Eisenberg CA, Eisenberg LM. 5-Azacytidine Promotes the Transdifferentiation of Cardiac Cells to Skeletal Myocytes. Cell Reprogram. 2014.
Ivanoff S, Gruson B, Chantepie SP, Lemasle E, Merlusca L, Harrivel V, Charbonnier A, Votte P, Royer B, Marolleau J-P. 5-azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy. Am J Hematol. 2013.
Suksamai D, Racha S, Sriratanasak N, Chaotham C, Aphicho K, Lin AChan Khine, Chansriniyom C, Suwanborirux K, Chamni S, Chanvorachote P. 5--(-Boc-l-Alanine)-Renieramycin T Induces Cancer Stem Cell Apoptosis via Targeting Akt Signaling. Mar Drugs. 2022;20(4).
Yang T, Lin Q, Ren J, Chen P, Yuan X, Luo X, Liu T, Zheng J, Zheng Z, Zheng X, et al. A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies. Oncotarget. 2016.
Zhang J, Cui Y, Li X, Xiao Y, Liu L, Jia F, He J, Xie X, Parthasarathy S, Hao H, et al. 5F peptide promotes endothelial differentiation of bone marrow stem cells through activation of ERK1/2 signaling. Eur J Pharmacol. 2020:173051.
Sethy C, Kundu CNath. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. Biomed Pharmacother. 2021;137:111285.
Xu Z-Y, Tang J-N, Xie H-X, Du Y-A, Huang L, Yu P-F, Cheng X-D. 5-Fluorouracil Chemotherapy of Gastric Cancer Generates Residual Cells with Properties of Cancer Stem Cells. Int J Biol Sci. 2015;11(3):284-294.
Gambino G, Ippolito C, Modeo L, Salvetti A, Rossi L. 5-fluorouracil-treated planarians, a versatile model system for studying stem cell heterogeneity and tissue aging. Biol Cell. 2020.
Su M, Kirchner A, Stazzoni S, Müller M, Wagner M, Schröder A, Carell T. 5-Formylcytosine Could Be a Semipermanent Base in Specific Genome Sites. Angew Chem Int Ed Engl. 2016.
Gao Y, Li L, Yuan P, Zhai F, Ren Y, Yan L, Li R, Lian Y, Zhu X, Wu X, et al. 5-Formylcytosine landscapes of human preimplantation embryos at single-cell resolution. PLoS Biol. 2020;18(7):e3000799.
Wong JC, Weinfurtner KM, Westover T, Kim J, Lebish EJ, Alzamora MDel Pilar, Huang BJ, Walsh M, Abdelhamed S, Ma J, et al. 5G2 mutant mice model loss of a commonly deleted segment of chromosome 7q22 in myeloid malignancies. Leukemia. 2024.
Uribe-Lewis S, Stark R, Carroll T, Dunning MJ, Bachman M, Ito Y, Stojic L, Halim S, Vowler SL, Lynch AG, et al. 5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer. Genome Biol. 2015;16(1):69.
Takaki M, Goto K, Kawahara I. The 5-hydroxytryptamine 4 Receptor Agonist-induced Actions and Enteric Neurogenesis in the Gut. J Neurogastroenterol Motil. 2014;20(1):17-30.
Gordeeva O, Safandeev V. 5-Hydroxytryptophan (5-HTP)-induced intracellular syndrome in mouse non-neural embryonic cells is associated with inhibited proliferation and cell death. Neuropharmacology. 2019:107862.
Tang D, Hu Y, Gao W. 5-lipoxygenase as a target to sensitize glioblastoma to temozolomide treatment via β-catenin-dependent pathway. Neurol Res. 2023:1-9.
Kaut O, Kuchelmeister K, Moehl C, Wüllner U. 5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinson's disease. J Chem Neuroanat. 2018.
Etikasari R, Andayani TMurti, Endarti D, Taroeno-Hariadi KWidayati. The 5-Year Disease-Free Survival of Third Generation Aromatase Inhibitor for Postmenopausal Women with HR-Positive HER2-Negative Non-Metastatic Breast Cancer. Int J Hematol Oncol Stem Cell Res. 2023;17(1):48-55.

Pages